SEVOXACIN

This brand name is authorized in Nigeria.

Active ingredients

The drug SEVOXACIN contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA - DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-7399	Tablet	Sevoxacin Tablets TAB 500 mg 1 x 10's (in a carton)	Film Coated Tablet Orange colored, capsule shaped, biconvex, film coated tablet, break line on one side, plain on other side 40 CMS-PP-404565 SEVOXACIN TABLETS LEVOFLOXACIN 500MG Levofloxacin Tablets USP 500 mg EXCIPIENTS: Q.S 422Oct-99 Drugs Imported Products 1X10 Prescription Only Medicine (POM) TIM GREAT PHARMACEUTICAL VENTURES LTD, No. 39, Niger Street, of M/M Way, Opposite GLO Office, Kano State. 8184435083 timgreatpharma1@gmail.com IMPULSE PHARMA PVT.LTD, J-201, J-202/1, M.I.D.C., Tarapur, Boisar, Dist. Palghar - 401 506, Maharashtra State, India., India	30/04/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-7399